Who Supplies Daratumumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Daratumumab exports, with 36+ registered manufacturers shipping to buyers across 23+ countries — yet a handful of companies dominate the shipments. VAMA LIFECARE PRIVATE LIMITED holds the largest share at 20.1% (export value: $268.2K). Close behind, NIVIRA EXPORTS (14.4%, $192.9K). M. CARE (7.6%, $102.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Daratumumab? Top Manufacturers & Their Buyers
Flow of Daratumumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Daratumumab Supplier Network — Key Market Intelligence
The Daratumumab export market from India is led by VAMA LIFECARE PRIVATE LIMITED, which alone commands a 20.1% share, shipping $268.2K worth of product across 29 shipments. The second-largest exporter, NIVIRA EXPORTS, contributes $192.9K (14.4%) to the overall market. Combined, the top two suppliers alone account for 34.5% of all Daratumumab exports, indicating a relatively concentrated supply base.
Across all 36 tracked manufacturers, the total Daratumumab export value stands at $1.3M from 209 shipments. The market average shipment value is $6.4K. The single largest buyer relationship in terms of trade value is AS PER INVOICE BRAZIL, receiving $93.8K worth of product.
The combined buyer network spans 10 named purchasing companies, including AS PER INVOICE BRAZIL, AS PER INVOICE AS, EXP CODE, AS PER INVOICE, TO THE and 5 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1VAMA LIFECARE PRIVATE LIMITED
VAMA LIFECARE PRIVATE LIMITED is the first-largest Daratumumab exporter from India, with a market share of 20.1% and a total export value of $268.2K across 29 shipments. Their average shipment value of $9.2K is above the market average of $6.4K, suggesting premium or bulk contract pricing.
VAMA LIFECARE PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AS PER INVOICE BRAZIL — $93.8K across 10 shipments (35.0% of this supplier's total exports)
• AS PER INVOICE AS — $74.3K across 8 shipments (27.7% of this supplier's total exports)
• EXP CODE — $69.0K across 7 shipments (25.7% of this supplier's total exports)
• AS PER INVOICE — $21.8K across 2 shipments (8.1% of this supplier's total exports)
• TO THE — $9.4K across 1 shipments (3.5% of this supplier's total exports)
Key Insight: VAMA LIFECARE PRIVATE LIMITED's per-shipment value of $9.2K is 45% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.
2NIVIRA EXPORTS
NIVIRA EXPORTS is the second-largest Daratumumab exporter from India, with a market share of 14.4% and a total export value of $192.9K across 33 shipments. Their average shipment value of $5.8K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.
NIVIRA EXPORTS serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE CONCERN PERSON — $72.5K across 12 shipments (37.6% of this supplier's total exports)
• MARIA MARIANA DA SILVA CPF N — $53.8K across 9 shipments (27.9% of this supplier's total exports)
• JOAO DE SOUZA MARTINS — $29.9K across 5 shipments (15.5% of this supplier's total exports)
• GENILSON FRANCISCO DE SANTANA — $22.8K across 4 shipments (11.8% of this supplier's total exports)
• AVANY TAVARES DE — $13.9K across 2 shipments (7.2% of this supplier's total exports)
Key Insight: NIVIRA EXPORTS operates with high shipment frequency (33 shipments) at a per-shipment value of $5.8K, indicating a broad distribution network with many smaller, regular orders.
3M. CARE
M. CARE is the third-largest Daratumumab exporter from India, with a market share of 7.6% and a total export value of $102.1K across 6 shipments. Their average shipment value of $17.0K is above the market average of $6.4K, suggesting premium or bulk contract pricing.
M. CARE serves 1 named buyer in our database. TO THE ORDER is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $102.1K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: M. CARE's per-shipment value of $17.0K is 166% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.
4DOSHI MEDICARE PRIVATE LIMITED
DOSHI MEDICARE PRIVATE LIMITED is the fourth-largest Daratumumab exporter from India, with a market share of 7.4% and a total export value of $98.7K across 23 shipments. Their average shipment value of $4.3K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.
DOSHI MEDICARE PRIVATE LIMITED serves 1 named buyer in our database. TO THE ORDER OF is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $98.7K across 23 shipments (100.0% of this supplier's total exports)
Key Insight: DOSHI MEDICARE PRIVATE LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $4.3K, indicating a broad distribution network with many smaller, regular orders.
53S PHARMACEUTICALS INDIA PRIVATE LIMITED
3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the fifth-largest Daratumumab exporter from India, with a market share of 4.9% and a total export value of $64.9K across 9 shipments. Their average shipment value of $7.2K is above the market average of $6.4K, suggesting premium or bulk contract pricing.
3S PHARMACEUTICALS INDIA PRIVATE LIMITED serves 2 named buyers in our database. FOR THE ORDER OF is the dominant customer, accounting for 94.2% of this supplier's tracked business. Top customers include:
• FOR THE ORDER OF — $61.2K across 8 shipments (94.2% of this supplier's total exports)
• FOR THE ORDER OF RIC — $3.7K across 1 shipments (5.8% of this supplier's total exports)
Key Insight: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $7.2K is 13% above the market average of $6.4K, consistent with large-order contracts or value-added formulations.
6VEA IMPEX (I) PRIVATE LIMITED
VEA IMPEX (I) PRIVATE LIMITED is the fifth-largest Daratumumab exporter from India, with a market share of 3.5% and a total export value of $46.8K across 9 shipments. Their average shipment value of $5.2K is below the market average of $6.4K, reflecting a high-volume, competitive pricing strategy.
VEA IMPEX (I) PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER OF INVO is the dominant customer, accounting for 65.1% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF INVO — $30.5K across 6 shipments (65.1% of this supplier's total exports)
• TO THE ORDER OF INVO — $16.3K across 3 shipments (34.9% of this supplier's total exports)
Key Insight: VEA IMPEX (I) PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $5.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Daratumumab Flows
Once Daratumumab leaves the manufacturing plants of companies like VAMA LIFECARE PRIVATE LIMITED and NIVIRA EXPORTS, it travels to 5 destination markets with a combined import value of $1.3M. Brazil absorbs the largest share at 45.9% ($613.3K), followed by Cayman Islands (9.4%) and Oman (7.6%).
In Brazil — the top destination — named importers include AS PER INVOICE BRAZIL, AS PER INVOICE AS, TO THE CONCERN PERSON.
This geographic spread reflects Daratumumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Daratumumab Go? Top Importing Countries & Their Buyers
Trade flow of Daratumumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Brazil
Brazil ranks as the first-largest destination for Daratumumab imports from India, with a total trade value of $613.3K across 56 shipments — representing a 45.9% share of all Daratumumab exports. The average shipment value of $11.0K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Daratumumab importers in Brazil: AS PER INVOICE BRAZIL is the largest buyer, accounting for 15.3% ($93.8K) of this market's total imports.
• AS PER INVOICE BRAZIL — $93.8K (15.3% of Brazil's total)
• AS PER INVOICE AS — $74.3K (12.1% of Brazil's total)
• TO THE CONCERN PERSON — $72.5K (11.8% of Brazil's total)
Key Insight: Brazil's per-shipment average of $11.0K (71% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Daratumumab imports from India.
2Cayman Islands
Cayman Islands ranks as the second-largest destination for Daratumumab imports from India, with a total trade value of $125.7K across 0 shipments — representing a 9.4% share of all Daratumumab exports. The average shipment value of $125.7K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: Cayman Islands's per-shipment average of $125.7K (1865% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Cayman Islands is a key market for Daratumumab imports from India.
3Oman
Oman ranks as the third-largest destination for Daratumumab imports from India, with a total trade value of $102.1K across 0 shipments — representing a 7.6% share of all Daratumumab exports. The average shipment value of $102.1K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: Oman's per-shipment average of $102.1K (1498% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Oman is a key market for Daratumumab imports from India.
4Zimbabwe
Zimbabwe ranks as the fourth-largest destination for Daratumumab imports from India, with a total trade value of $60.7K across 0 shipments — representing a 4.5% share of all Daratumumab exports. The average shipment value of $60.7K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations.
Key Insight: Zimbabwe's per-shipment average of $60.7K (849% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Zimbabwe is a key market for Daratumumab imports from India.
5Georgia
Georgia ranks as the fifth-largest destination for Daratumumab imports from India, with a total trade value of $59.1K across 8 shipments — representing a 4.4% share of all Daratumumab exports. The average shipment value of $7.4K is above the global average of $6.4K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Daratumumab importers in Georgia: MERMISI LLC is the largest buyer, accounting for 91.4% ($54.0K) of this market's total imports.
• MERMISI LLC — $54.0K (91.4% of Georgia's total)
Key Insight: Georgia's per-shipment average of $7.4K (16% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Georgia is a key market for Daratumumab imports from India.
People Also Ask — Daratumumab Supplier & Trade Network
Who are the top suppliers of Daratumumab from India?+
Which companies buy Daratumumab from Indian manufacturers?+
Where does Daratumumab exported from India go?+
What is the market share of the top Daratumumab supplier from India?+
What is the average shipment value for Daratumumab exports from India?+
Is Daratumumab manufactured in India and exported globally?+
Which country imports the most Daratumumab from India?+
Who are the buyers of Daratumumab in Cayman Islands?+
How concentrated is the Daratumumab supplier market in India?+
How do I find verified buyers for Daratumumab in specific countries?+
Daratumumab Trade Network — Key Takeaways
- 1VAMA LIFECARE PRIVATE LIMITED is India's dominant Daratumumab exporter with a 20.1% market share and $268.2K in total exports — making it the single most important sourcing entity in this market.
- 2The top 36 suppliers collectively account for 57.9% of all tracked Daratumumab exports, with a combined trade value of $1.3M.
- 3Brazil is the largest destination market, absorbing 45.9% of India's Daratumumab exports ($613.3K). Cayman Islands (9.4%) and Oman (7.6%) follow.
- 4With 209 total shipments averaging $6.4K each, the Daratumumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AS PER INVOICE BRAZIL, AS PER INVOICE AS, TO THE CONCERN PERSON, MARIA MARIANA DA SILVA CPF N — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 23 countries
Network value: $1.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Daratumumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Daratumumab.
- 2.Flow Mapping: 36 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 209 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 23 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
209 Verified Shipments
36 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists